Literature DB >> 17660808

A step forward for restless legs syndrome.

Emmanuel Mignot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17660808     DOI： 10.1038/ng0807-938

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  9 in total

Review 1.  From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.

Authors:  Daniel W Nebert; Ge Zhang; Elliot S Vesell
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

2.  Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population.

Authors:  Qinbo Yang; Lin Li; Qiuyun Chen; Nancy Foldvary-Schaefer; William G Ondo; Qing Kenneth Wang
Journal:  Sleep Med       Date:  2011-09       Impact factor: 3.492

3.  Family-based and population-based association studies validate PTPRD as a risk factor for restless legs syndrome.

Authors:  Qinbo Yang; Lin Li; Rong Yang; Gong-Qing Shen; Qiuyun Chen; Nancy Foldvary-Schaefer; William G Ondo; Qing Kenneth Wang
Journal:  Mov Disord       Date:  2011-01-24       Impact factor: 10.338

4.  Depth and Distribution of Symptoms in Restless Legs Syndrome/ Willis-Ekbom Disease.

Authors:  Paul Yeh; William G Ondo; Daniel L Picchietti; J Steven Poceta; Richard P Allen; Charles R Davies; Lily Wang; Yaping Shi; Kanika Bagai; Arthur S Walters
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

5.  MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels.

Authors:  Lan Xiong; Hélène Catoire; Patrick Dion; Claudia Gaspar; Ronald G Lafrenière; Simon L Girard; Anastasia Levchenko; Jean-Baptiste Rivière; Laura Fiori; Judith St-Onge; Isabelle Bachand; Pascale Thibodeau; Richard Allen; Christopher Earley; Gustavo Turecki; Jacques Montplaisir; Guy A Rouleau
Journal:  Hum Mol Genet       Date:  2009-01-06       Impact factor: 6.150

6.  Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders.

Authors:  Seong-Jin Cho; Jin Pyo Hong; Bong-Jin Hahm; Hong Jin Jeon; Sung Man Chang; Maeng Je Cho; Hochang B Lee
Journal:  Sleep       Date:  2009-08       Impact factor: 5.849

7.  Haplotype Association of the MAP2K5 Gene with Antipsychotics-Induced Symptoms of Restless Legs Syndrome among Patients with Schizophrenia.

Authors:  Seung-Gul Kang; Yu Jin Lee; Young-Min Park; Leen Kim; Heon-Jeong Lee
Journal:  Psychiatry Investig       Date:  2018-01-16       Impact factor: 2.505

8.  Astrocyte-specific overexpressed gene signatures in response to methamphetamine exposure in vitro.

Authors:  Nikki Bortell; Liana Basova; Svetlana Semenova; Howard S Fox; Timothy Ravasi; Maria Cecilia G Marcondes
Journal:  J Neuroinflammation       Date:  2017-03-09       Impact factor: 8.322

9.  A direct interaction between two Restless Legs Syndrome predisposing genes: MEIS1 and SKOR1.

Authors:  Helene Catoire; Faezeh Sarayloo; Karim Mourabit Amari; Sergio Apuzzo; Alanna Grant; Daniel Rochefort; Lan Xiong; Jacques Montplaisir; Christopher J Earley; Gustavo Turecki; Patrick A Dion; Guy A Rouleau
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.